AnaptysBio, Inc.
US ˙ NasdaqGS ˙ US0327241065

SecurityANAB / AnaptysBio, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Alps Advisors Inc closes position in ANAB / AnaptysBio, Inc.

On February 12, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 0 shares of AnaptysBio, Inc. (US:ANAB) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 5, 2025 disclosing 13,335 shares of AnaptysBio, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-12 2025-12-31 13F ANAPTYSBIO COM 032724106 0 -100.00 0
2025-11-05 2025-09-30 13F ANAPTYSBIO COM 032724106 13,335 -2,528 -15.94 408 15.91 0.0023
2025-08-11 2025-06-30 13F ANAPTYSBIO COM 032724106 15,863 -7,263 -31.41 352 -17.95 0.0020
2025-04-30 2025-03-31 13F ANAPTYSBIO COM 032724106 23,126 -1,478 -6.01 430 32.00 0.0025
2025-02-13 2024-12-31 13F ANAPTYSBIO COM 032724106 24,604 3,092 14.37 326 -54.86 0.0021
2024-11-12 2024-09-30 13F ANAPTYSBIO COM 032724106 21,512 183 0.86 721 34.83 0.0048
2024-08-13 2024-06-30 13F ANAPTYSBIO COM 032724106 21,329 2,582 13.77 535 26.54 0.0037
2024-05-14 2024-03-31 13F ANAPTYSBIO COM 032724106 18,747 679 3.76 422 9.04 0.0030
2024-02-14 2023-12-31 13F ANAPTYSBIO COM 032724106 18,068 -1,506 -7.69 387 10.26 0.0030
2023-11-14 2023-09-30 13F ANAPTYSBIO COM 032724106 19,574 104 0.53 352 -11.36 0.0029
2023-08-14 2023-06-30 13F ANAPTYSBIO COM 032724106 19,470 1,071 5.82 396 -1.00 0.0034
2023-05-10 2023-03-31 13F ANAPTYSBIO COM 032724106 18,399 -887 -4.60 400 -33.00 0.0035
2023-02-14 2022-12-31 13F ANAPTYSBIO COM 032724106 19,286 3,917 25.49 598 52.30 0.0053
2022-11-14 2022-09-30 13F ANAPTYSBIO COM 032724106 15,369 -1,352 -8.09 392 15.63 0.0037
2022-08-15 2022-06-30 13F/A-1 ANAPTYSBIO COM 032724106 16,721 -11,718 -41.20 339 -51.85 0.0033
2022-08-11 2022-06-30 13F ANAPTYSBIO COM 032724106 16,721 -11,718 339 0.0032
2022-05-16 2022-03-31 13F ANAPTYSBIO COM 032724106 28,439 -3,392 -10.66 704 -36.35 0.0076
2022-02-09 2021-12-31 13F ANAPTYSBIO COM 032724106 31,831 -1,792 -5.33 1,106 21.27 0.0124
2021-11-15 2021-09-30 13F ANAPTYSBIO COM 032724106 33,623 -2,422 -6.72 912 -2.46 0.0088
2021-08-11 2021-06-30 13F ANAPTYSBIO COM 032724106 36,045 -13,429 -27.14 935 -12.29 0.0083
2021-05-07 2021-03-31 13F ANAPTYSBIO COM 032724106 49,474 122 0.25 1,066 0.47 0.0104
2021-02-03 2020-12-31 13F ANAPTYSBIO COM 032724106 49,352 14,538 41.76 1,061 106.42 0.0119
2020-11-05 2020-09-30 13F/A-1 ANAPTYSBIO COM 032724106 34,814 -2,396 -6.44 514 -38.15 0.0076
2020-11-04 2020-09-30 13F ANAPTYSBIO COM 032724106 34,814 -2,396 514 6,587.5258
2020-08-05 2020-06-30 13F ANAPTYSBIO COM 032724106 37,210 37,210 831 0.0111
2020-02-07 2019-12-31 13F ANAPTYSBIO COMMON STOCK 032724106 0 -53,927 -100.00 0 -100.00
2019-11-04 2019-09-30 13F ANAPTYSBIO COMMON STOCK 032724106 53,927 -2,636 -4.66 1,887 -40.86 0.0147
2019-08-07 2019-06-30 13F ANAPTYSBIO COMMON STOCK 032724106 56,563 -8,053 -12.46 3,191 -32.39 0.0236
2019-05-01 2019-03-31 13F ANAPTYSBIO COMMON STOCK 032724106 64,616 2,797 4.52 4,720 19.71 0.0334
2019-02-04 2018-12-31 13F ANAPTYSBIO COMMON STOCK 032724106 61,819 19,284 45.34 3,943 -7.09 0.0306
2018-10-25 2018-09-30 13F ANAPTYSBIO COMMON STOCK 032724106 42,535 8,441 24.76 4,244 75.23 0.0278
2018-08-02 2018-06-30 13F/A-2 AnaptysBio COMMON STOCK 032724106 34,094 2,579 8.18 2,422 -26.16 0.0158
2018-07-31 2018-06-30 13F/A-1 AnaptysBio COMMON STOCK 032724106 26,038 -8,056 2,623 0.0168
2018-07-25 2018-06-30 13F AnaptysBio COMMON STOCK 032724106 26,038 -5,477 2,623
2018-05-01 2018-03-31 13F AnaptysBio COMMON STOCK 032724106 31,515 5,477 21.03 3,280 25.05 0.0261
2018-02-20 2017-12-31 13F/A-1 AnaptysBio COMMON STOCK 032724106 26,038 6,004 29.97 2,623 274.71 0.0182
2018-02-05 2017-12-31 13F AnaptysBio COMMON STOCK 032724106 26,038 6,004 2,623
2017-11-03 2017-09-30 13F AnaptysBio COMMON STOCK 032724106 20,034 1,824 10.02 700 60.55 0.0050
2017-08-03 2017-06-30 13F AnaptysBio COMMON STOCK 032724106 18,210 18,210 436 0.0030
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.